JP2022107004A5 - - Google Patents

Download PDF

Info

Publication number
JP2022107004A5
JP2022107004A5 JP2022079329A JP2022079329A JP2022107004A5 JP 2022107004 A5 JP2022107004 A5 JP 2022107004A5 JP 2022079329 A JP2022079329 A JP 2022079329A JP 2022079329 A JP2022079329 A JP 2022079329A JP 2022107004 A5 JP2022107004 A5 JP 2022107004A5
Authority
JP
Japan
Prior art keywords
assay method
sob
supernatant
sodium
glass tube
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022079329A
Other languages
English (en)
Other versions
JP2022107004A (ja
Filing date
Publication date
Priority claimed from JP2020147224A external-priority patent/JP7075455B2/ja
Application filed filed Critical
Publication of JP2022107004A publication Critical patent/JP2022107004A/ja
Publication of JP2022107004A5 publication Critical patent/JP2022107004A5/ja
Pending legal-status Critical Current

Links

Claims (7)

  1. 人工小腸有機および無機緩衝液(SOB)アッセイ法であって、下記工程:
    1)アミンポリマーを提供する工程、
    2)pH6.2に緩衝化された50mM 2-(N-モルホリノ)エタンスルホン酸(MES)、50mM 酢酸ナトリウム、36mM 塩化ナトリウム、7mM リン酸ナトリウム、1.5mM クエン酸ナトリウム、30mM オレイン酸および5mM タウロコール酸ナトリウムを含むSOB緩衝液をアミンポリマーに添加し、最終ポリマー濃度2.5mg/mlを達成する工程、
    3)混合物を回転式ミキサーで撹拌しながら37℃で2時間インキュベートする工程、
    4)600マイクロリットルの上清を取る工程、
    5)上清を濾過する工程、
    6)濾液を希釈する工程、および
    7)イオンクロマトグラフィーを使用してアニオン含量を測定する工程
    を含む、アッセイ法。
  2. アミンポリマーが液密スクリューキャップを備えたガラス管において提供されるものである、請求項1に記載のSOBアッセイ法。
  3. ガラス管が16×100mmガラス管である、請求項2に記載のSOBアッセイ法。
  4. 96ウェルガラスフィルタープレートを使用して上清を濾過する、請求項1~3のいずれか一項に記載のSOBアッセイ法。
  5. ガラスフィルタープレートが底に取り付けた収集プレートを有するものである、請求項4に記載のSOBアッセイ法。
  6. フィルタープレートおよび収集プレートを1000×gで1分遠心分離する、請求項5に記載のSOBアッセイ法。
  7. シリンジフィルターを使用して上清を濾過する、請求項1~3のいずれか一項に記載のSOBアッセイ法。
JP2022079329A 2013-06-05 2022-05-13 経口投与用プロトン結合ポリマー Pending JP2022107004A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361831445P 2013-06-05 2013-06-05
US61/831,445 2013-06-05
JP2020147224A JP7075455B2 (ja) 2013-06-05 2020-09-02 経口投与用プロトン結合ポリマー

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020147224A Division JP7075455B2 (ja) 2013-06-05 2020-09-02 経口投与用プロトン結合ポリマー

Publications (2)

Publication Number Publication Date
JP2022107004A JP2022107004A (ja) 2022-07-20
JP2022107004A5 true JP2022107004A5 (ja) 2022-10-19

Family

ID=51212941

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016518006A Active JP6453860B2 (ja) 2013-06-05 2014-06-05 経口投与用プロトン結合ポリマー
JP2018233254A Active JP6759316B2 (ja) 2013-06-05 2018-12-13 経口投与用プロトン結合ポリマー
JP2020147224A Active JP7075455B2 (ja) 2013-06-05 2020-09-02 経口投与用プロトン結合ポリマー
JP2022079329A Pending JP2022107004A (ja) 2013-06-05 2022-05-13 経口投与用プロトン結合ポリマー

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2016518006A Active JP6453860B2 (ja) 2013-06-05 2014-06-05 経口投与用プロトン結合ポリマー
JP2018233254A Active JP6759316B2 (ja) 2013-06-05 2018-12-13 経口投与用プロトン結合ポリマー
JP2020147224A Active JP7075455B2 (ja) 2013-06-05 2020-09-02 経口投与用プロトン結合ポリマー

Country Status (25)

Country Link
US (8) US9205107B2 (ja)
EP (4) EP3812761A1 (ja)
JP (4) JP6453860B2 (ja)
KR (4) KR102318910B1 (ja)
CN (3) CN105377270B (ja)
AU (3) AU2014274817B2 (ja)
BR (1) BR112015030142B1 (ja)
CA (1) CA2912911C (ja)
CY (3) CY1119611T1 (ja)
DK (3) DK3578185T3 (ja)
ES (3) ES2733493T3 (ja)
HK (3) HK1222120A1 (ja)
HR (3) HRP20171590T1 (ja)
HU (3) HUE043999T2 (ja)
IL (3) IL242758B (ja)
LT (3) LT3003327T (ja)
MX (3) MX364785B (ja)
NO (1) NO2905572T3 (ja)
PL (2) PL3003327T3 (ja)
PT (3) PT3287133T (ja)
RS (2) RS61005B1 (ja)
RU (1) RU2728778C2 (ja)
SI (3) SI3287133T1 (ja)
TR (1) TR201909355T4 (ja)
WO (1) WO2014197725A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014274817B2 (en) * 2013-06-05 2019-05-23 Tricida, Inc. Proton-binding polymers for oral administration
ES2857177T3 (es) 2014-12-10 2021-09-28 Tricida Inc Polímeros de unión de protones para administración oral
SG11201809605PA (en) * 2016-05-06 2018-11-29 Tricida Inc Compositions for and method of treating acid-base disorders
WO2018124264A1 (ja) 2016-12-28 2018-07-05 富士フイルム株式会社 窒素原子含有ポリマー又はその塩の乳化液、その製造方法、及び粒子の製造方法
US10934380B1 (en) 2017-09-25 2021-03-02 Tricida, Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
TW201922267A (zh) 2017-10-16 2019-06-16 日商富士軟片股份有限公司 高磷血症治療劑
US20210187011A1 (en) * 2017-11-03 2021-06-24 Tricida, Inc. Method of treating acid-base disorders
SG11202003451UA (en) 2017-11-03 2020-05-28 Tricida Inc Compositions for and method of treating acid-base disorders
WO2019236636A1 (en) * 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
JP2022540707A (ja) * 2019-07-19 2022-09-16 アカテコール・インコーポレイテッド 分子的に十分に規定された生物付着防止ポリイオンコーティング
EP4053179A1 (en) 2021-03-01 2022-09-07 Tricida Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
WO2023109825A1 (zh) * 2021-12-14 2023-06-22 上海石趣医药科技有限公司 氧化银和/或其水合物在制备药物中的用途
CN115260355A (zh) * 2022-05-16 2022-11-01 江苏中天药业有限公司 一种阴离子交换树脂、其制备方法、该树脂与药物的复合物和其掩味制剂
KR20230047972A (ko) 2023-03-21 2023-04-10 최문수 개인별 맞춤형 그립 형상이 형성된 운동기구용 손잡이

Family Cites Families (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050090553A1 (en) 1992-06-30 2005-04-28 Shapiro Howard K. Compositions and method for treatment of chronic inflammatory diseases
US6444221B1 (en) 1992-06-30 2002-09-03 Howard K. Shapiro Methods of treating chronic inflammatory diseases using carbonyl trapping agents
CA2202397C (en) 1994-10-17 2002-07-16 Peter W. Stacpoole Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders
US5534259A (en) * 1993-07-08 1996-07-09 Liposome Technology, Inc. Polymer compound and coated particle composition
US5496545A (en) 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5648355A (en) 1994-02-09 1997-07-15 Kos Pharmaceutical, Inc. Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
TW474813B (en) 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
US20020006899A1 (en) 1998-10-06 2002-01-17 Pospisilik Andrew J. Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
US5753706A (en) 1996-12-16 1998-05-19 Hsu; Chen Hsing Methods for treating renal failure
AUPO758297A0 (en) 1997-06-27 1997-07-24 Rowe, James Baber Control of acidic gut syndrome
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
WO1999040990A1 (en) 1998-02-17 1999-08-19 University Of Maryland Anion binding polymers and the use thereof
US6485703B1 (en) 1998-07-31 2002-11-26 The Texas A&M University System Compositions and methods for analyte detection
US6271264B1 (en) 1998-12-01 2001-08-07 Geltex Pharmaceuticals, Inc. Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB9927088D0 (en) 1999-11-17 2000-01-12 Secr Defence Use of poly(diallylamine) polymers
US6844372B2 (en) 2000-03-09 2005-01-18 Hisamitsu Pharmaceutical Co., Inc. Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same
WO2001066606A1 (fr) 2000-03-09 2001-09-13 Hisamitsu Pharmaceutical Co., Inc. Resine echangeuse d'anions reticulee ou sel de celle-ci
AU2001241095A1 (en) 2000-03-13 2001-09-24 Hisamitsu Pharmaceutical Co. Inc. Preventives and/or remedies for hyperphosphatemia
JP2002028737A (ja) 2000-07-07 2002-01-29 Fujitsu Ltd プレス打ち抜き加工方法及びプレス打ち抜き加工装置
BR0209133A (pt) 2001-04-18 2004-06-15 Genzyme Corp Método para tratar gota e para reduzir os nìveis de ácido úrico n0 sangue
BR0209020A (pt) * 2001-04-18 2004-08-10 Genzyme Corp Composição farmacêutica de polialilamina
CN1274668C (zh) 2002-03-11 2006-09-13 诺瓦提斯公司 那格列奈的盐
US20070135335A1 (en) 2003-02-10 2007-06-14 Autogen Research Pty Ltd. Therapeutic molecules
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
CN1540136A (zh) * 2003-10-27 2004-10-27 华东理工大学 一种评价微生物驱油能力的方法
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7449605B2 (en) 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
CA2551528A1 (en) 2003-12-31 2005-07-21 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
EP1723968A1 (en) 2004-01-29 2006-11-22 Keio University Erythrocyte function modifying substance
US7854924B2 (en) 2004-03-30 2010-12-21 Relypsa, Inc. Methods and compositions for treatment of ion imbalances
US8282960B2 (en) 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
JP5000480B2 (ja) 2004-03-30 2012-08-15 レリプサ, インコーポレイテッド イオンバランス異常の治療の方法および組成物
US7429394B2 (en) 2004-03-30 2008-09-30 Relypsa, Inc. Ion binding compositions
US8192758B2 (en) 2004-03-30 2012-06-05 Relypsa, Inc. Ion binding compositions
US7556799B2 (en) 2004-03-30 2009-07-07 Relypsa, Inc. Ion binding polymers and uses thereof
US8399025B2 (en) 2004-06-04 2013-03-19 Board Of Regents, The University Of Texas System Polyamine modified particles
CN101022821B (zh) 2004-07-19 2014-01-29 纽崔西亚公司 天冬氨酸用于调节血中葡萄糖水平的用途
DE102004035808A1 (de) 2004-07-21 2006-03-16 Kasch, Helmut, Dr. Ammoniumsalze und Ammoniumsalz-Mineralsalzchlatrate als Transport- und Wirkform für pharmazeutische-medizinische und als Phasentransfermittel für chemische Anwendungen
US8569277B2 (en) 2004-08-11 2013-10-29 Palo Alto Investors Methods of treating a subject for a condition
US20080214440A1 (en) 2004-10-08 2008-09-04 Forbes Medi-Tech (Research), Inc. Vasoactive intestinal polypeptide compositions
US20070293429A1 (en) 2004-10-08 2007-12-20 Therapei Pharmaceuticals, Inc. Vasoactive Intestinal Polypeptide Compositions
AU2005296290A1 (en) * 2004-10-13 2006-04-27 Ilypsa, Inc. Crosslinked amine polymers
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
ITME20040015A1 (it) 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
AU2006264407B2 (en) 2005-07-04 2012-08-30 Ramu Krishnan Improved drug or pharmaceutical compounds and a preparation thereof
CA2619591C (en) 2005-08-18 2020-03-24 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
WO2007027566A2 (en) 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
WO2007038801A2 (en) 2005-09-30 2007-04-05 Ilypsa, Inc. Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof
CA2624170C (en) * 2005-09-30 2014-02-25 Ilypsa, Inc. Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
DE112006002617T5 (de) 2005-09-30 2008-08-28 Ilypsa Inc., Santa Clara Verfahren zur Herstellung von Core-Shell-Kompositen bzw. Kern-Hüllen-Kompositen mit vernetzten Hüllen und daraus entstehende Core-Shell-Komposite
KR101119847B1 (ko) 2005-11-08 2012-03-14 아지노모토 가부시키가이샤 마취 각성 촉진제
BRPI0618352A2 (pt) 2005-11-08 2011-08-23 Genzyme Corp composições farmacêuticas e métodos de tratamento da hiperfosfatemia em um paciente
ITMI20052461A1 (it) 2005-12-22 2007-06-23 Univ Degli Studi Milano Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive
RU2008136081A (ru) 2006-02-14 2010-03-20 Тева Фармасьютикл Индастриес Лтд. (Il) Фармацевтические составы с алифатическими аминными полимерами и способы их производства
US20080085259A1 (en) 2006-05-05 2008-04-10 Huval Chad C Amine condensation polymers as phosphate sequestrants
JP2009542653A (ja) 2006-07-05 2009-12-03 ジェンザイム コーポレーション リン酸塩過剰血症のための鉄(ii)含有治療剤
MX2009000611A (es) 2006-07-18 2009-04-16 Genzyme Corp Dendrimeros de amina.
CN101541235A (zh) * 2006-07-18 2009-09-23 基酶有限公司 胺类树状物
US8391873B2 (en) 2006-07-21 2013-03-05 Qualcomm Incorporated Systems and methods for coordinating supplementary services for voice telephone calls in a centralized fashion
WO2008016729A1 (en) 2006-08-04 2008-02-07 Nastech Pharmaceutical Company Inc. Compositions for intranasal delivery of human insulin and uses thereof
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
EP2068819A4 (en) * 2006-09-01 2011-04-20 Genzyme Corp Dendrimer COMPOSITIONS
RU2009111853A (ru) 2006-09-01 2010-10-10 Юсв Лимитед (In) Способ получения гидрохлорида севеламера и его лекарственной формы
US7868045B2 (en) 2006-09-06 2011-01-11 Sucampo Ag Method for promoting gastrointestinal bicarbonate secretion
BRPI0717545A2 (pt) 2006-09-29 2013-10-22 Gezyme Corp Composição farmacêutica, método para tratar uma doença, polímero de amida, rede de polímero, e, método para preparar um polímero de amida
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
US20100129309A1 (en) 2007-02-23 2010-05-27 Dhal Pradeep K Amine polymer compositions
US20080207766A1 (en) 2007-02-27 2008-08-28 Agi Therapeutics Research Ltd. Methods and compositions for treating at least one upper gastrointestinal symptom
WO2008109095A1 (en) 2007-03-08 2008-09-12 Genzyme Corporation Sulfone polymer compositions
TWI445540B (zh) 2007-04-20 2014-07-21 Ajinomoto Kk 抗低體溫組成物
US20100166696A1 (en) 2007-04-27 2010-07-01 Dhal Pradeep K Amido-amine dendrimer compositions
WO2009005838A2 (en) 2007-07-02 2009-01-08 Cognate3 Llc Process for the preparation of a non-corrosive base solution and methods of using same
KR20100045965A (ko) * 2007-07-11 2010-05-04 도레이 카부시키가이샤 가교 폴리알릴아민 또는 그 산부가염 및 그 의약 용도
EP2016947A1 (en) 2007-07-17 2009-01-21 Chemo Ibérica, S.A. Novel one step process for preparing cross-linked poly(allylamine) polymers
WO2009023544A2 (en) 2007-08-10 2009-02-19 Ilypsa, Inc. Dosage unit anion-exchange polymer pharmaceutical compositions
US20090156647A1 (en) 2007-12-12 2009-06-18 Iovate T. & P. Inc. Method for maintaining physiological pH levels during intensive physical exercise
PA8807201A1 (es) 2007-12-14 2009-07-23 Genzyme Corp Composiciones farmaceuticas
JP2011506449A (ja) 2007-12-14 2011-03-03 ジェンザイム コーポレーション コーティング医薬組成物
WO2009097127A1 (en) 2008-01-31 2009-08-06 Genzyme Corporation Pharmaceutical compositions
WO2009114650A1 (en) 2008-03-11 2009-09-17 Chakshu Research, Inc. Methods and compositions for treating inflammation and inflammation-related pathologies
US20100331516A1 (en) 2008-04-08 2010-12-30 Govind Dhananjay Sathe Process for Preparation of Sevelamer Carbonate
ES2380162T3 (es) 2008-04-11 2012-05-09 Gp Investimenti S.R.L. Dispositivo de uso manual para el tratamiento de tejido humano con ultrasonidos
WO2009154747A1 (en) 2008-06-20 2009-12-23 Genzyme Corporation Pharmaceutical compositions
DE102008030046A1 (de) 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
US20100008988A1 (en) 2008-07-14 2010-01-14 Glenmark Generics, Ltd. Tablet compositions of amine polymers
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
US20100104527A1 (en) 2008-08-22 2010-04-29 Relypsa, Inc. Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
WO2010022380A2 (en) 2008-08-22 2010-02-25 Relypsa, Inc. Linear polyol stabilized polyfluoroacrylate compositions
CA2737452C (en) 2008-09-25 2018-05-22 Vive Nano Inc. Methods to produce polymer nanoparticles and formulations of active ingredients
WO2010035273A2 (en) 2008-09-29 2010-04-01 Intec Pharma Ltd. Novel gastroretentive delivery system
WO2010059384A1 (en) 2008-10-30 2010-05-27 Janssen Pharmaceutica Nv Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists
US20100166861A1 (en) 2008-12-29 2010-07-01 Kelly Noel Lynch Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone
AU2010209293A1 (en) 2009-01-22 2011-09-08 Usv Limited Pharmaceutical compositions comprising phosphate-binding polymer
US8945508B2 (en) 2009-10-13 2015-02-03 The Regents Of The University Of Michigan Dendrimer compositions and methods of synthesis
DK2490675T3 (en) 2009-10-22 2019-04-29 Synthon Bv Pharmaceutical compositions with sevelamer
WO2011071927A2 (en) 2009-12-07 2011-06-16 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
WO2011106542A2 (en) 2010-02-24 2011-09-01 Relypsa, Inc. Crosslinked polyvrnylamine, poly all ylamine, and polyethyleneimine for use as bile acid sequestrants
AU2011220745B2 (en) 2010-02-24 2016-12-01 Relypsa, Inc. Polyimidazoles for use as bile acid sequestrants
RU2417782C1 (ru) * 2010-03-03 2011-05-10 Федеральное государственное образовательное учреждение высшего профессионального образования "Белгородская государственная сельскохозяйственная академия" Способ лечения ацидоза рубца
IT1406068B1 (it) 2010-07-22 2014-02-06 Medestea Int Spa Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
KR101238210B1 (ko) 2011-06-30 2013-03-04 엘지전자 주식회사 이동 단말기
US20130137772A1 (en) 2011-11-29 2013-05-30 Raymond J. Bergeron Hydroxypolyamine salts
EA201590062A1 (ru) 2012-06-21 2016-02-29 Керикс Байофармасьютикалз, Инк. Применение лимонно-кислого железа при лечении пациентов с хронической почечной недостаточностью
CA2886788C (en) 2012-10-08 2022-04-19 Relypsa, Inc. Potassium-binding agents for treating hypertension and hyperkalemia
AU2014274817B2 (en) 2013-06-05 2019-05-23 Tricida, Inc. Proton-binding polymers for oral administration
BR112016009901A8 (pt) 2013-11-04 2020-04-14 Keryx Biopharmaceuticals Inc uso de citrato férrico
ES2857177T3 (es) 2014-12-10 2021-09-28 Tricida Inc Polímeros de unión de protones para administración oral
SG11201809605PA (en) 2016-05-06 2018-11-29 Tricida Inc Compositions for and method of treating acid-base disorders
SG11202003451UA (en) 2017-11-03 2020-05-28 Tricida Inc Compositions for and method of treating acid-base disorders
US20210187011A1 (en) 2017-11-03 2021-06-24 Tricida, Inc. Method of treating acid-base disorders
WO2019236639A1 (en) 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
WO2019236636A1 (en) 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
WO2019236124A1 (en) 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders

Similar Documents

Publication Publication Date Title
JP2022107004A5 (ja)
Hutchinson et al. Improved blood free selective medium for the isolation of campylobacter jejuni from faecal specimens.
Aisner et al. Torulopsis glabrata infections in patients with cancer: increasing incidence and relationship to colonization
Van Krimpen et al. Penicillins and cephalosporins: physicochemical properties and analysis in pharmaceutical and biological matrices
Brown et al. “Penbritin”—A New Broad-spectrum Antibiotic
CN104805073A (zh) 一种用于病毒基因组核酸提取试剂盒及其方法
CN105560194B (zh) 高纯度的头孢他啶粉针剂及其制备方法
US20180105862A1 (en) Novel method for detecting the presence of beta-lactamase-producing bacteria
CN102190710A (zh) 多黏菌素e2组合物及其制备方法和用途
Solangi et al. Quantitative analysis of eight cephalosporin antibiotics in pharmaceutical products and urine by capillary zone electrophoresis
DE102022130395A1 (de) Verfahren zur Aufkonzentrierung mindestens einer Zielsubstanz in einem Flüssigkeitsvolumen
CN103374562A (zh) 一种酶固定化方法
CN104876946A (zh) 一种治疗感染性疾病的舒巴坦钠化合物及其制备方法
CN113552259A (zh) 一种快速检测产a/b类碳青霉烯酶肠杆菌科细菌的试剂盒与检测方法
CN107805267B (zh) 一种甲钴胺及其衍生物的纯化方法
TWI532840B (zh) 微生物抗藥性與抗生素最小抑制濃度之檢測方法
CN109490460B (zh) 一种l-2-氨基-5-胍基戊酸有关物质的检测方法
Chien et al. Centrifugal packing of suspensions of erythrocytes hardened with acetaldehyde
CN102824345B (zh) 一种盐酸伊立替康组合物及其制备方法
DE69936527T2 (de) Verwendung von modifiziertem lysozyme c in der herstellung von pharmazeutika zur krankheitsbehandlung
Osei-Asare et al. Evaluation of the microbial quality of commercial liquid herbal preparations on the Ghanaian market
CN111235212A (zh) 一种盐酸莫西沙星原料药微生物限度检查测定方法
Maartens et al. Antibiotic resistance in community-acquired urinary tract infections
CN109575010B (zh) 从黄连提取母液中提取甲基小檗碱的方法、由其制备的高纯度甲基小檗碱及应用
CN112684017A (zh) 淡水鱼中环丙沙星和恩诺沙星含量的检测方法